Share
Journal Information
Issue
Vol. 27. Issue 1.Pages 1-90 (January - February 2021)
Download full issue
Download sponsored by SPP
Commentaries
Challenges for the female health-care workers during the COVID-19 pandemic: the need for protection beyond the mask
Claudia Crimi, Annalisa Carlucci
Pulmonol. 2021;27:1-3
Open access
Open Article
Tuberculosis — Reaping benefits from COVID-19 in Portugal
B.L. Mateiro Gomes, I. Carvalho
Pulmonol. 2021;27:4-6
Open access
Open Article
Original articles
Original articles
Interstitial lung diseases
Translating Idiopathic pulmonary fibrosis guidelines into clinical practice
C. Robalo-Cordeiro, A. Morais
Pulmonol. 2021;27:7-13
Open access
Low dose computed tomography of the lung for detection and grading of interstitial lung disease: A systematic simulation study
S. Ley, L. Fidler, H. Schenk, M. Durand, T. Marras, N. Paul, S. Shapera, S. Mittoo
Pulmonol. 2021;27:14-25
Open access
Original articles
Lung cancer
The effect of different treatment modalities on survival in elderly patients with locally advanced non-small cell lung cancer
A. Sakin, S. Sahin, M.M. atci, N. Yasar, C. Geredeli, F. Aksaray, S. Cihan
Pulmonol. 2021;27:26-34
Open access
Original articles
Tuberculosis
Risk factors for early mortality in patients with pulmonary tuberculosis admitted to the emergency room
R. Singla, B. Raghu, A. Gupta, J.A. Caminero, P. Sethi, D. Tayal, A. Chakraborty, Y. Jain, G.B. Migliori
Pulmonol. 2021;27:35-42
Open access
Reviews
The role of non-invasive ventilation in weaning and decannulating critically ill patients with tracheostomy: A narrative review of the literature
Miguel Guia, Laura D Ciobanu, Jithin K Sreedharan, Mohamed E. Abdelrahim, Gil Gonçalves, Bruno Cabrita, Jaber S. Alqahtani, Jun Duan, ... on behalf of International Association of Non Invasive Ventilation
Pulmonol. 2021;27:43-51
Open access
Rationale and evidence on the use of tocilizumab in COVID-19: a systematic review
A. Cortegiani, M. Ippolito, M. Greco, V. Granone, A. Protti, C. Gregoretti, A. Giarratano, S. Einav, M. Cecconi
Pulmonol. 2021;27:52-66
Open access
Open Article
Letters to the editor
COVID-19 effects on tuberculosis care in Sierra Leone
D. Buonsenso, F. Iodice, J. Sorba Biala, D. Goletti
Pulmonol. 2021;27:67-9
Open access
Open Article
Extracorporeal membranous oxygenation for a severe case of vaping associated lung injury
M.R. Regmi, N. Tandan, P. Parajuli, R. Maini, O.E. Lara Garcia, P. Jagtap, A. Kulkarni
Pulmonol. 2021;27:69-70
Open access
The “Big Five” Lung Diseases in CoViD-19 Pandemic – a Google Trends analysis
M.T. Barbosa, M. Morais-Almeida, C.S. Sousa, J. Bousquet
Pulmonol. 2021;27:71-2
Open access
Total volume/week of physical activity: an underused variable of physical activity in daily life in patients with copd and its association with exercise capacity
Lorena P. Schneider, Felipe V.C. Machado, Antenor Rodrigues, Raquel P. Hirata, Daniele C. Dala Pola, Mariana P. Bertoche, Letícia F. Belo, Ana Carolina dos Reis Andrello, ... Fabio Pitta
Pulmonol. 2021;27:73-5
Open access
Rhodococcus equi infection as inaugural manifestation of idiopathic CD4+ lymphopenia: A rare entity and a therapeutic challenge
A. Alves, E. Silva, T. Teixeira, C. Figueiredo, A. Lameirão, M. Vanzeller, C. Ribeiro
Pulmonol. 2021;27:75-7
Open access
First case report in Latin America: Oral treatment of multidrug-resistant tuberculosis with delamanid and bedaquiline in combination with linezolid, moxifloxacin and clofazimine following a DRESS syndrome in a peruvian patient
S. Pecho-Silva, A.C. Navarro-Solsol
Pulmonol. 2021;27:77-9
Open access
Alpha-1-antitrypsin deficiency (AATD) and spontaneous pneumothorax: Guidelines do not recommend screening for AATD in patients with pneumothorax – What did we find in 10 years of clinical evidence?
E. Dias, I. Farinha, F. Costa
Pulmonol. 2021;27:80-1
Open access
Secondary pulmonary alveolar proteinosis in a patient with systemic lupus erythematosus
M. Yamasaki, K. Kawamoto, S. Nakano, M. Taniwaki, N. Matsumoto, N. Hattori
Pulmonol. 2021;27:81-3
Open access
Correspondence
Pneumonia mortality, comorbidities matter? Authors’ answer
V. Hespanhol, Cristina Bárbara
Pulmonol. 2021;27:85-6
Open access
Interleukin-6 blockade with tocilizumab in COVID-19: Does it live up to its hype?
C.S. Kow, S.S. Hasan
Pulmonol. 2021;27:86-7
Open access
Open Article
Rationale and evidence on the use of tocilizumab in COVID-19: A systematic review. Authors’ reply
A. Cortegiani, M. Ippolito, S. Einav
Pulmonol. 2021;27:87-8
Open access
Open Article
Spontaneous pneumomediastinum: Beyond the risky diving
Jordi Juanola-Pla, Mireia Carmona-Tomàss, Sonia Casals-Vila
Pulmonol. 2021;27:88-9
Open access
Wearing masks and the fight against the novel coronavirus (COVID-19)
Javad Alizargar
Pulmonol. 2021;27:89
Open access
Open access
This work is licensed under a Creative Commons Attribution 4.0 International License.
Publish in
Pulmonology
